TY - JOUR AU - Miquel-Cases, Anna AU - Steuten, Lotte M. G. AU - Rigter, Lisanne S. AU - van Harten, Wim H. PY - 2016 DA - 2016/09/05 TI - Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands JO - BMC Cancer SP - 712 VL - 16 IS - 1 AB - Response-guided neoadjuvant chemotherapy (RG-NACT) with magnetic resonance imaging (MRI) is effective in treating oestrogen receptor positive/human epidermal growth factor receptor-2 negative (ER-positive/HER2-negative) breast cancer. We estimated the expected cost-effectiveness and resources required for its implementation compared to conventional-NACT. SN - 1471-2407 UR - https://doi.org/10.1186/s12885-016-2653-y DO - 10.1186/s12885-016-2653-y ID - Miquel-Cases2016 ER -